Neuropharmacology Journal Citation Rate 2026
0028-3908
eISSN 1873-7064
Elsevier BV
NL
Q1 Quartile Established Impact
About Neuropharmacology
Neuropharmacology (N) is a peer-reviewed academic journal covering Ion channel regulation and function and Neuropeptides and Animal Physiology, published by Elsevier BV in NL, catalogued under ISSN 0028-3908 (e-ISSN 1873-7064). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 3.37 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4050 USD).
Neuropharmacology Citation Rate 2026 — In Context
Neuropharmacology has a 2025 2-Year Citation Rate (OpenAlex) of 3.37, placing it in the Q1 quartile within the Ion channel regulation and function research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Neuropharmacology operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Neuropharmacology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Neuropharmacology against similar journals in the field, use our journal comparison tool.
Submission Tips for Neuropharmacology
- Budget $4050 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Ion channel regulation and function, Neuropeptides and Animal Physiology, Neuroscience and Neuropharmacology Research. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Neuropharmacology Compares
Compared against 54 journals in the same research areas.
| ISSN (Print) | 0028-3908 |
|---|---|
| ISSN (Online) | 1873-7064 |
| Publisher | Elsevier BV |
| Country | Netherlands |
| APC / Cost | $4050 USD |
In-depth profile & metrics
Neuropharmacology is published by Elsevier BV and based in Netherlands. It runs on a subscription or hybrid model with an article-processing charge of USD 4050.
In our subject taxonomy, Neuropharmacology is classified under Ion channel regulation and function, Neuropeptides and Animal Physiology, Neuroscience and Neuropharmacology Research and Neurotransmitter Receptor Influence on Behavior.
Neuropharmacology is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 3.370.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Neuropharmacology
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 3.370 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Neuropharmacology against similar publications in its field:
Related Journals in Your Field
-
Neuron Cell Press IF 11.68
-
Pharmacology & Therapeutics Elsevier BV IF 10.38
-
Pharmacological Research Elsevier BV IF 9.37
-
Trends in Pharmacological Sciences Elsevier BV IF 8.53
-
Neuroscience & Biobehavioral Reviews Elsevier BV IF 6.82
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S160566677
Get weekly updates for Ion channel regulation and function journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.